MX2009010925A - Combinaciones de estatinas y agente anti-obesidad. - Google Patents
Combinaciones de estatinas y agente anti-obesidad.Info
- Publication number
- MX2009010925A MX2009010925A MX2009010925A MX2009010925A MX2009010925A MX 2009010925 A MX2009010925 A MX 2009010925A MX 2009010925 A MX2009010925 A MX 2009010925A MX 2009010925 A MX2009010925 A MX 2009010925A MX 2009010925 A MX2009010925 A MX 2009010925A
- Authority
- MX
- Mexico
- Prior art keywords
- combinations
- statins
- obesity agent
- obesity
- orlistat
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Se describe la co-terapia de un agente anti-obesidad, una estatina, junto con combinaciones fijas de los mismos. Atorvastatina y orlistat son preferidos como los diversos componentes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92245407P | 2007-04-09 | 2007-04-09 | |
PCT/US2008/004492 WO2008124120A1 (en) | 2007-04-09 | 2008-04-07 | Combinations of statins and anti-obesity agent |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009010925A true MX2009010925A (es) | 2009-11-02 |
Family
ID=39827136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009010925A MX2009010925A (es) | 2007-04-09 | 2008-04-07 | Combinaciones de estatinas y agente anti-obesidad. |
Country Status (11)
Country | Link |
---|---|
US (3) | US20080248115A1 (es) |
EP (1) | EP2131835A1 (es) |
JP (1) | JP2010523659A (es) |
KR (1) | KR20090127904A (es) |
CN (1) | CN101795684A (es) |
AP (1) | AP2009005026A0 (es) |
AU (1) | AU2008236616A1 (es) |
CA (1) | CA2681449A1 (es) |
IL (1) | IL201247A0 (es) |
MX (1) | MX2009010925A (es) |
WO (1) | WO2008124120A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2012260605B2 (en) | 2011-05-20 | 2015-02-19 | Astrazeneca Uk Limited | Pharmaceutical composition of rosuvastatin calcium |
US8252312B1 (en) * | 2011-12-27 | 2012-08-28 | David Wong | Oral solid composition comprising a lipid absorption inhibitor |
CN102552168B (zh) * | 2012-01-31 | 2013-08-07 | 杭州华东医药集团生物工程研究所有限公司 | 一种含有奥利司他的药物组合物及其制备方法 |
WO2014107619A1 (en) * | 2013-01-04 | 2014-07-10 | Second Genome, Inc. | Microbiome modulation index |
CN108440456B (zh) * | 2018-03-22 | 2020-01-03 | 中山万汉制药有限公司 | 奥利司他与有机酸钙的共晶体及包含该共晶体的药物组合物 |
CN110314232A (zh) * | 2019-08-03 | 2019-10-11 | 黄泳华 | 由脂肪酶抑制剂与羟甲戊二酰辅酶a还原酶抑制剂构成的组合物 |
WO2022129004A1 (en) * | 2020-12-15 | 2022-06-23 | Dsm Ip Assets B.V. | Coated statin tablet comprising vitamin e acetate powder |
WO2022129003A1 (en) * | 2020-12-15 | 2022-06-23 | Dsm Ip Assets B.V. | Multiparticulate solid oral dosage form comprising statin and vitamin e |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4231938A (en) * | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
MX7065E (es) * | 1980-06-06 | 1987-04-10 | Sankyo Co | Un procedimiento microbiologico para preparar derivados de ml-236b |
ZA821577B (en) * | 1981-04-06 | 1983-03-30 | Boots Co Plc | Therapeutic agents |
US4448784A (en) * | 1982-04-12 | 1984-05-15 | Hoechst-Roussel Pharmaceuticals, Inc. | 1-(Aminoalkylphenyl and aminoalkylbenzyl)-indoles and indolines and analgesic method of use thereof |
US5354772A (en) * | 1982-11-22 | 1994-10-11 | Sandoz Pharm. Corp. | Indole analogs of mevalonolactone and derivatives thereof |
CA1247547A (en) * | 1983-06-22 | 1988-12-28 | Paul Hadvary | Leucine derivatives |
DE3402495A1 (de) * | 1984-01-25 | 1985-07-25 | Steinbock Gmbh, 8052 Moosburg | Deichselgelenktes foerdergeraet |
GB8531071D0 (en) * | 1985-12-17 | 1986-01-29 | Boots Co Plc | Therapeutic compound |
US4681893A (en) * | 1986-05-30 | 1987-07-21 | Warner-Lambert Company | Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis |
US4940727A (en) * | 1986-06-23 | 1990-07-10 | Merck & Co., Inc. | Novel HMG-CoA reductase inhibitors |
USRE36481E (en) * | 1986-06-23 | 2000-01-04 | Merck & Co., Inc. | HMG-CoA reductase inhibitors |
US5030447A (en) * | 1988-03-31 | 1991-07-09 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions having good stability |
US5180589A (en) * | 1988-03-31 | 1993-01-19 | E. R. Squibb & Sons, Inc. | Pravastatin pharmaceuatical compositions having good stability |
IE61928B1 (en) * | 1988-11-29 | 1994-11-30 | Boots Co Plc | Treatment of obesity |
FI94339C (fi) * | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
US5622985A (en) * | 1990-06-11 | 1997-04-22 | Bristol-Myers Squibb Company | Method for preventing a second heart attack employing an HMG CoA reductase inhibitor |
JP2648897B2 (ja) * | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
HU9203780D0 (en) * | 1991-12-12 | 1993-03-29 | Sandoz Ag | Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them |
ATE178794T1 (de) * | 1993-01-19 | 1999-04-15 | Warner Lambert Co | Stabilisierte, oral anzuwendende zusammensetzung enthaltend die verbindung ci-981 und verfahren |
BR9609872A (pt) * | 1995-07-17 | 1999-03-23 | Warner Lambert Co | Hemi sal de cálcio de ácido (R-(R*R*)]-2-(4-fluorfenil-)-beta delta-diidróxi-5-(1-metiletil)-3-fenil-4- [(fenilamino) carbonil]-1H- pirrol-1heptanóico (atorvasta-tina)c ristalino |
GB9900339D0 (en) * | 1999-01-09 | 1999-02-24 | Zeneca Ltd | Chemical compounds |
US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
GB0001621D0 (en) * | 2000-01-26 | 2000-03-15 | Astrazeneca Ab | Pharmaceutical compositions |
AU4916501A (en) * | 2000-03-14 | 2001-09-24 | Noven Pharmaceuticals, Inc. | Packaging materials for transdermal drug delivery systems |
US7053080B2 (en) * | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
AR044152A1 (es) * | 2003-05-09 | 2005-08-24 | Bayer Corp | Derivados de alquilarilo, metodo de preparacion y uso para el tratamiento de la obesidad |
US20060148721A1 (en) * | 2003-06-06 | 2006-07-06 | Erondu Ngozi E | Combination therapy for the treatment of dyslipidemia |
WO2006002127A1 (en) * | 2004-06-21 | 2006-01-05 | Fairfield Clinical Trials, Llc | Transdermal delivery system for statin combination therapy |
US20060280791A1 (en) * | 2005-04-08 | 2006-12-14 | Ju Tzuchi R | Pharmaceutical formulations |
US20070092553A1 (en) * | 2005-10-21 | 2007-04-26 | Pfab Lp | Compositions and methods of making rapidly dissolving lonically masked formulations |
-
2008
- 2008-04-07 CN CN200880010880A patent/CN101795684A/zh active Pending
- 2008-04-07 US US12/080,950 patent/US20080248115A1/en not_active Abandoned
- 2008-04-07 JP JP2010503026A patent/JP2010523659A/ja active Pending
- 2008-04-07 KR KR1020097020510A patent/KR20090127904A/ko not_active Application Discontinuation
- 2008-04-07 AU AU2008236616A patent/AU2008236616A1/en not_active Abandoned
- 2008-04-07 MX MX2009010925A patent/MX2009010925A/es not_active Application Discontinuation
- 2008-04-07 CA CA002681449A patent/CA2681449A1/en not_active Abandoned
- 2008-04-07 WO PCT/US2008/004492 patent/WO2008124120A1/en active Application Filing
- 2008-04-07 AP AP2009005026A patent/AP2009005026A0/en unknown
- 2008-04-07 EP EP08742607A patent/EP2131835A1/en not_active Withdrawn
-
2009
- 2009-09-30 IL IL201247A patent/IL201247A0/en unknown
-
2010
- 2010-05-21 US US12/800,771 patent/US20100234443A1/en not_active Abandoned
- 2010-05-21 US US12/800,732 patent/US20100239669A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20100239669A1 (en) | 2010-09-23 |
IL201247A0 (en) | 2010-05-31 |
AP2009005026A0 (en) | 2009-12-31 |
EP2131835A1 (en) | 2009-12-16 |
KR20090127904A (ko) | 2009-12-14 |
CN101795684A (zh) | 2010-08-04 |
US20080248115A1 (en) | 2008-10-09 |
US20100234443A1 (en) | 2010-09-16 |
AU2008236616A1 (en) | 2008-10-16 |
JP2010523659A (ja) | 2010-07-15 |
WO2008124120A1 (en) | 2008-10-16 |
CA2681449A1 (en) | 2008-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009010925A (es) | Combinaciones de estatinas y agente anti-obesidad. | |
EP2644194A3 (en) | Combinations of an anti-HER2 antibody-drug conjugate and docetaxel | |
HK1110761A1 (en) | Compression anastomosis ring assembly and applicator for use therewith | |
CL2008000649S1 (es) | Banda de rodadura. | |
UY32277A (es) | Derivados de n-{[1r,4s,6r)-3-(2-piridinilcarbonil)-3-azabiciclo[4.1.0-il}metil}-2heteroarilamina y uso de los mismos | |
PL2285490T3 (pl) | Dwumetaliczne kompleksy katalityczne do kopolimeryzacji dwutlenku węgla i epoksydu | |
ZA200706980B (en) | Spiroketal-substituted cyclic ketoenols | |
EA200900781A1 (ru) | 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды | |
MX2009003938A (es) | Anticuerpos e inmunoconjugados y sus usos. | |
BRPI0919949A2 (pt) | Simbiose micorrízica arbuscular estimuladora de lipoquito-oligossacarídeos | |
EP1888095A4 (en) | MODULATORS OF ALPHA SYNUCLEINE TOXICITY | |
IL180423A0 (en) | Combinations of statins with bronchodilators | |
WO2009025850A3 (en) | Copolymerization of epoxides and cyclic anhydrides | |
MX2011009458A (es) | Derivados de rosuvastatina y atorvastatina. | |
NL1027655A1 (nl) | N-Alkylpyrrolen als HMG-CoA-reductaseremmers. | |
BRPI0913586A8 (pt) | combinação, e, uso de uma combinação. | |
PT1942891E (pt) | Nova combinação de fármacos como antidepressivo | |
MY183345A (en) | Apparatus for coastal protection | |
CA127538S (en) | Clipboard | |
AU311455S (en) | Cycle mudguard | |
ES1059759Y (es) | Multibolsa de basura. | |
ES1059446Y (es) | Mesa redonda ampliable de extension radial | |
UA29770U (ru) | Применение мигрепина как вещества с противоболевыми свойствами | |
UA36194U (en) | Use of quercetin as hepatoprotector | |
UY3718Q (es) | Mobiliario de oficina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |